Lymphoma, Leukemia & Myeloma Congress

Directions Website

Lymphoma, Leukemia & Myeloma Congress The premier forum for healthcare professionals who study and manage patients with lymphoma, myeloma

For the past sixteen years, L&M has been the premier forum on the latest advances in lymphoma and myeloma. Over forty internationally-recognized leaders in molecular biology, pathology, immunology, translational and clinical research have been involved to provide expertise and guidance on recent developments in the basic science, translational medicine and clinical trials. The Congress features an interdisciplinary approach, special lectures, debates and interactive techniques to explore the controversial, the upcoming, and the exciting in myeloma, Waldenstrom’s macroglobulinemia, chronic lymphatic leukemia, lymphoma and Hodgkin’s disease.

Welcome to the 26th Lymphoma, Leukemia & Myeloma Congress! We’re excited to welcome you today at the New York Marriott M...
10/13/2026

Welcome to the 26th Lymphoma, Leukemia & Myeloma Congress! We’re excited to welcome you today at the New York Marriott Marquis. Today’s focus is leukemia. We’re looking forward to a day of clinical insights and conversations with colleagues from across the hematology-oncology community.

Follow along with us online throughout the week. Share your experience using , or stop by booth #122 and tell us what you think.

Tomorrow, we kick off the 26th Annual LL&M Congress, bringing together the brightest minds in hematologic malignancies f...
10/12/2026

Tomorrow, we kick off the 26th Annual LL&M Congress, bringing together the brightest minds in hematologic malignancies for another year of groundbreaking science, expert insights, and meaningful connections.

For 26 years, LL&M Congress has been a place where the hematology community comes together to learn, collaborate, and advance patient care.

Here’s to continuing that legacy. See you tomorrow!

In four days, the New York Marriott Marquis fills with people sharing how they treat leukemia, lymphoma, myeloma, and CL...
10/09/2026

In four days, the New York Marriott Marquis fills with people sharing how they treat leukemia, lymphoma, myeloma, and CLL. Tuesday starts at 7:45 AM with ALL and ends with a talk on all-oral AML therapy. We’ll bring you along for an inside look.

09/28/2026

A treatment can be highly effective and still leave an essential question unanswered. Is it the right choice for this patient?

As evidence in CLL continues to develop, John Allan, MD, is examining how clinicians can approach that question while balancing treatment optimization with safety.

https://hubs.ly/Q04xcBM40

09/22/2026

Knowing which therapies are available is only one part of treating CLL. The harder task is building a strategy that makes sense for the individual patient.

John Allan, MD, previews how his LL&M Congress session will help clinicians work through these decisions and return to practice with insights they can apply.

Hear what attendees can expect, then make plans to join us in New York, October 13–16.
https://hubs.ly/Q04xczWp0

Complex hematologic cancer care depends on the clinical judgment that NPs and PAs provide every day.During National APP ...
09/21/2026

Complex hematologic cancer care depends on the clinical judgment that NPs and PAs provide every day.

During National APP Week, we recognize their role in guiding patients through treatment and responding as their needs change. We are grateful to the NPs and PAs across hematology and oncology for the knowledge and care they bring to every patient interaction. Thank you all!

09/17/2026

More treatment options do not necessarily make the next decision easier.

For older patients with recurrent diffuse large B-cell lymphoma, the evidence does not always provide a clear path through an evolving treatment landscape. John Leonard, MD, examines the practical question clinicians still need to resolve.

Watch his perspective, then join the lymphoma community at LL&M Congress in New York, October 13–16.
https://hubs.ly/Q04xczBs0

How is ALL care changing in 2026and what do these advances mean for treatment decisions? At the LLM Congress, “Transform...
09/16/2026

How is ALL care changing in 2026and what do these advances mean for treatment decisions?

At the LLM Congress, “Transforming ALL Care: Targeted Therapy, MRD-Guided Decisions, and CAR T Advances” will explore:
• Optimizing TKI selection and combination strategies in Ph+ ALL
• Using MRD to personalize treatment and inform transplant decisions
• Expanding lower-toxicity T-cell redirection strategies in the community

Explore emerging evidence and practical insights you can apply to the decisions you face in practice today.

Registration rates increase after Friday, September 18. Register now: https://hubs.ly/Q04xB3L30

Lymphoma encompasses many distinct diseases, so the path from diagnosis to treatment is not the same for every patient.O...
09/15/2026

Lymphoma encompasses many distinct diseases, so the path from diagnosis to treatment is not the same for every patient.

On World Lymphoma Awareness Day, we recognize those living with lymphoma and the clinicians and researchers working to improve care across its many subtypes.

09/14/2026

A regimen may be supported by clinical trial data, but applying it to an older or frail patient can raise a different set of questions.

Joseph Mikhael, MD, MEd, FRCPC, FACP, previews the practical challenge he will address at LL&M Congress. Watch now, then join him in New York for a closer look at individualizing multiple myeloma treatment.

October 13–16, 2026
https://hubs.ly/Q04xczkh0

Address

811 W 7th Avenue
New York, NY

Alerts

Be the first to know and let us send you an email when Lymphoma, Leukemia & Myeloma Congress posts news and promotions. Your email address will not be used for any other purpose, and you can unsubscribe at any time.

Shortcuts

Share